Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Plasma (human) Chemical Compounds
Tandem Mass Spectrometry Medicine & Life Sciences
Mass spectrometry Chemical Compounds
Liquid Chromatography Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2017

Adaptation to TKI treatment reactivates ERK signaling in tyrosine kinase–driven leukemias and other malignancies

Bruner, J. K., Ma, H. S., Li, L., Qin, A. C. R., Rudek, M. A., Jones, R. J., Levis, M. J., Pratz, K. W., Pratilas, C. A. & Small, D. Oct 15 2017 In : Cancer Research. 77, 20, p. 5554-5563 10 p.

Research output: Research - peer-reviewArticle

Protein-Tyrosine Kinases
Leukemia
Neoplasms
Acute Myeloid Leukemia
Mitogen-Activated Protein Kinase Kinases

A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Gojo, I. , Beumer, J. H. , Pratz, K. W. , McDevitt, M. A. , Baer, M. R. , Blackford, A. L. , Smith, B. D. , Gore, S. D. , Carraway, H. E. , Showel, M. M. , Levis, M. J. , Dezern, A. E. , Gladstone, D. E. , Ji, J. J. , Wang, L. , Kinders, R. J. , Pouquet, M. , Ali-Walbi, I. , Rudek, M. A. , Poh, W. & 5 others Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E. Feb 1 2017 In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

Research output: Research - peer-reviewArticle

temozolomide
Acute Myeloid Leukemia
Poly(ADP-ribose) Polymerase Inhibitors
veliparib
Methylation

A phase Ib study of sorafenib (BAY 43-9006) in patients with Kaposi sarcoma

Uldrick, T. S., Gonçalves, P. H., Wyvill, K. M., Peer, C. J., Bernstein, W., Aleman, K., Polizzotto, M. N., Venzon, D., Steinberg, S. M., Marshall, V., Whitby, D., Little, R. F., Wright, J. J., Rudek, M. A., Figg, W. D. & Yarchoan, R. May 1 2017 In : Oncologist. 22, 5

Research output: Research - peer-reviewArticle

Kaposi's Sarcoma
sorafenib
Ritonavir
HIV
Area Under Curve

A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia

Pratz, K. W., Rudek, M. A., Gojo, I., Litzow, M. R., McDevitt, M. A., Ji, J., Karnitz, L. M., Herman, J. G., Kinders, R. J., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Gladstone, D. E., Levis, M. J., Tsai, H. L., Rosner, G., Chen, A., Kaufmann, S. H. & Karp, J. E. Feb 15 2017 In : Clinical Cancer Research. 23, 4, p. 899-907 9 p.

Research output: Research - peer-reviewArticle

Leukemia, Myelomonocytic, Chronic
Topotecan
Carboplatin
Leukemia
Neoplasms

Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034

Tan, C. R. C., Barta, S. K., Lee, J., Rudek, M. A., Sparano, J. A. & Noy, A. Nov 22 2017 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-10 10 p.

Research output: Research - peer-reviewArticle

AIDS-Related Lymphoma
Drug Therapy
Therapeutics
HIV
CD4 Lymphocyte Count